Long-Term Prognostic Value of Preprocedural C-Reactive Protein After Drug-Eluting Stent Implantation

American Journal of Cardiology

Volumn 105, Issue 6, 2010, Pages 826-832

  Delhaye, Cedric ^a   Maluenda, Gabriel ^a   Wakabayashi, Kohei ^a   Ben Dor, Itsik ^a   Lemesle, Gilles ^a   Collins, Sara D ^a   Syed, Asmir I ^a   Torguson, Rebecca ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ACUTE CORONARY SYNDROME; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; REVASCULARIZATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 77649093849     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.064     Document Type: Article

References (30)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Libby P., and Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100 (1999) 1148-1150
3. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
4. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
5. Ortolani P., Marzocchi A., Marrozzini C., Palmerini T., Saia F., Taglieri N., Baldazzi F., Silenzi S., Bacchi-Reggiani M.L., Guastaroba P., Grilli R., and Branzi A. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. Eur Heart J 29 (2008) 1241-1249
6. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B., and European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349 (1997) 462-466
7. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., and Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
8. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., Braunwald E., and Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 98 (1998) 839-844
9. Lamblin N., Mouquet F., Hennache B., Dagorn J., Susen S., Bauters C., and de Groote P. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 26 (2005) 2245-2250
10. Sabatine M.S., Morrow D.A., Jablonski K.A., Rice M.M., Warnica J.W., Domanski M.J., Hsia J., Gersh B.J., Rifai N., Ridker P.M., Pfeffer M.A., and Braunwald E. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 (2007) 1528-1536
11. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schachinger V., and Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
12. Dibra A., Mehilli J., Braun S., Hadamitzky M., Baum H., Dirschinger J., Schuhlen H., Schomig A., and Kastrati A. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722
13. Chew D.P., Bhatt D.L., Robbins M.A., Penn M.S., Schneider J.P., Lauer M.S., Topol E.J., and Ellis S.G. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104 (2001) 992-997
14. Mueller C., Buettner H.J., Hodgson J.M., Marsch S., Perruchoud A.P., Roskamm H., and Neumann F.J. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 105 (2002) 1412-1415
15. Zairis M.N., Ambrose J.A., Manousakis S.J., Stefanidis A.S., Papadaki O.A., Bilianou H.I., Devoe M.C., Fakiolas C.N., Pissimissis E.G., Olympios C.D., and Foussas S.G. The impact of plasma levels of C-reactive protein, lipoprotein(a) and homocysteine on the long-term prognosis after successful coronary stenting: the Global Evaluation of New Events and Restenosis After Stent Implantation Study. J Am Coll Cardiol 40 (2002) 1375-1382
16. Delhaye C., Sudre A., Lemesle G., Marechaux S., Broucqsault D., Hennache B., Bauters C., and Lablanche J.M. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. Cardiovasc Revasc Med 10 (2009) 144-150
17. Ferrante G., Niccoli G., Biasucci L.M., Liuzzo G., Burzotta F., Galiuto L., Trani C., Rebuzzi A.G., and Crea F. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med 9 (2008) 156-165
18. Maluenda G., Lemesle G., and Waksman R. A critical appraisal of the safety and efficacy of drug-eluting stents. Clin Pharmacol Ther 85 (2009) 474-480
19. Karha J., Bavry A.A., Rajagopal V., Henderson M.R., Ellis S.G., and Brener S.J. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Am J Cardiol 98 (2006) 616-618
20. Park D.W., Lee C.W., Yun S.C., Kim Y.H., Hong M.K., Kim J.J., Park S.W., and Park S.J. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation. Heart 93 (2007) 1087-1092
21. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., Katus H.A., Newby L.K., Ravkilde J., Chaitman B., Clemmensen P.M., Dellborg M., Hod H., Porela P., Underwood R., Bax J.J., Beller G.A., Bonow R., Van der Wall E.E., Bassand J.P., Wijns W., Ferguson T.B., Steg P.G., Uretsky B.F., Williams D.O., Armstrong P.W., Antman E.M., Fox K.A., Hamm C.W., Ohman E.M., Simoons M.L., Poole-Wilson P.A., Gurfinkel E.P., Lopez-Sendon J.L., Pais P., Mendis S., Zhu J.R., Wallentin L.C., Fernandez-Aviles F., Fox K.M., Parkhomenko A.N., Priori S.G., Tendera M., Voipio-Pulkki L.M., Vahanian A., Camm A.J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Morais J., Brener S., Harrington R., Morrow D., Lim M., Martinez-Rios M.A., Steinhubl S., Levine G.N., Gibler W.B., Goff D., Tubaro M., Dudek D., and Al-Attar N. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
22. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., and Serruys P.W. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
23. Casl M.T., Surina B., Glojnaric-Spasic I., Pape E., Jagarinec N., and Kranjcevic S. Serum amyloid A protein in patients with acute myocardial infarction. Ann Clin Biochem 32 Pt 2 (1995) 196-200
24. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A., and Braunwald E. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
25. Morrow D.A., de Lemos J.A., Sabatine M.S., Wiviott S.D., Blazing M.A., Shui A., Rifai N., Califf R.M., and Braunwald E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation 114 (2006) 281-288
26. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto Jr. A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., Macfadyen J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., and Glynn R.J. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373 (2009) 1175-1182
27. Segev A., Kassam S., Buller C.E., Lau H.K., Sparkes J.D., Connelly P.W., Seidelin P.H., Natarajan M.K., Cohen E.A., and Strauss B.H. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J 25 (2004) 1029-1035
28. Dibra A., Ndrepepa G., Mehilli J., Dirschinger J., Pache J., Schuhlen H., Schomig A., and Kastrati A. Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents. Am J Cardiol 95 (2005) 1238-1240
29. Virmani R., Farb A., Guagliumi G., and Kolodgie F.D. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 15 (2004) 313-318
30. Valgimigli M., Malagutti P., van Mieghem C.A., Vaina S., Ligthart J.M., Sianos G., and Serruys P.W. Persistence of neointimal growth 12 months after intervention and occurrence of delayed restenosis in patients with left main coronary artery disease treated with drug-eluting stents. J Am Coll Cardiol 47 (2006) 1491-1494